1-3 of 3
Seung Tae Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

Open Access
Clinical Trials & Observations
Kirk E. Cahill, James K. Godfrey, Chadi Nabhan, Justin Kline, Peter A. Riedell, Kenneth S. Cohen, Sunil Narula, Theodore G. Karrison, Jessica Robertson, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Seung Tae Lee, Jennie Y. Law, Paul A.S. Fishkin, Iris Isufi, Mario Reyes Velasco, Jr, Lynne Kaminer, Sonali M. Smith
Journal: Blood Advances
Blood Adv bloodadvances.2025017092.
https://doi.org/10.1182/bloodadvances.2025017092
Published: 2025
Includes: Supplemental data
Journal Articles

NUP98 is rearranged in 5.0% of adult East Asian patients with AML

Free
Namsoo Kim, Yu Jeong Choi, Hyunsoo Cho, Ji Eun Jang, Seung-Tae Lee, Jaewoo Song, Jong Rak Choi, June-Won Cheong, Haerim Chung, Saeam Shin
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5122–5125.
https://doi.org/10.1182/bloodadvances.2024012960
Published: 2024
Includes: Supplemental data
Journal Articles

CEBPA double mutations associated with ABO antigen weakness in hematologic diseases

Free
Seung Jun Choi, Hyun Kyung Kim, Eun Jung Suh, Soon Sung Kwon, Saeam Shin, Seung-Tae Lee, Sinyoung Kim
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1487–1493.
https://doi.org/10.1182/bloodadvances.2023011572
Published: 2024
Includes: Supplemental data